By whole-genome expression profiling data, we compared the mRNA expression level of ALDH1A3 and ALDH1A1 in low-grade gliomas (LGG, n = 122) and high-grade gliomas (HGG, n = 179). This evidence concerns the gene ALDH1A1 and central nervous system cancer.